玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00660 玮俊生物科技

停牌 10-13 09:20:09

0.430

+0.000

0.00%

最高0.430	最低0.430	成交量0.00
今开0.430	昨收0.430	日振幅0.00%
总市值1.65亿	流通市值1.65亿	总股本3.84亿
成交额0.00	换手率0.00%	流通股本3.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00660","market":"HK","secType":"STK","nameCN":"玮俊生物科技","latestPrice":0.43,"timestamp":1791854409182,"preClose":0.43,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":384000000,"shares":384000000,"eps":-0.084305,"marketStatus":"停牌","change":0,"latestTime":"10-13 09:20:09","open":0.43,"high":0.43,"low":0.43,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"listingDate":728841600000,"exchange":"SEHK","adjPreClose":0.43,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"volumeRatio":0,"referTempSymbol":"02916","lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00660","defaultTab":"news","newsList":[{"id":"1167541345","title":"玮俊生物科技(00660)：主要附属公司财务经理突发缺勤致审计延迟，年度业绩预计11月上旬公布并继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1167541345","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167541345?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:06","pubTimestamp":1791367602,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司10月7日发布补充公告，说明截至2026年6月30日止年度业绩公布延迟的具体原因，并披露最新进度安排。该附属公司为集团在本财政年度内唯一产生收益的实体，其财务经理的缺勤直接影响了年度审计工作的开展及统筹。经与核数师协商，公司现预计将于2026年11月上旬公布2026年度业绩。玮俊生物科技股份自2026年10月2日上午9时起于联交所暂停买卖，直至刊发2026年度业绩为止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142941947","title":"玮俊生物科技2026年9月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1142941947","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142941947?lang=zh_cn&edition=full","pubTime":"2026-10-02 18:02","pubTimestamp":1790935320,"startTime":"0","endTime":"0","summary":"瑋俊生物科技有限公司于2026年10月2日发布2026年9月股份变动月报表，报告期为截至2026年9月30日。根据公告信息，公司已发行股份与注册股本等均保持稳定，未发生新增发行、回购或注销等变动。根据公告，截至2026年9月末，公司普通股法定股本总数为10,000,000,000股，面值均为每股0.01港元，总额约1亿港元，与上月保持一致。普通股已发行数为384,309,785股，较上月无变化，且不存在库存股份。本公告由公司执行董事林家俊签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672795863","title":"玮俊生物科技公布于10月2日上午起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2672795863","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672795863?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:25","pubTimestamp":1790904300,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端玮俊生物科技（00660）发布公告，公司股份将于2026年10月2日上午九时正起暂停买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-10-02/doc-inituwti4699351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672793468","title":"玮俊生物科技(00660)延迟刊发2026年度业绩 10月2日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2672793468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672793468?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:04","pubTimestamp":1790903078,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技 发布公告，由于公司及核数师需要额外时间完成审计工作，公司无法根据上市规则第13.49条的规定，于2026年9月30日或之前刊发2026年度业绩。根据上市规则，倘2026年度业绩未能于2026年9月30日前刊发，预期公司股份将于联交所暂停买卖，自该限期后下一个营业日上午9时正起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141842526","title":"玮俊生物科技（00660）公告延迟刊发2026年度业绩　或于10月2日起暂停买卖","url":"https://stock-news.laohu8.com/highlight/detail?id=1141842526","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141842526?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:01","pubTimestamp":1790902874,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司10月2日发布公告称，由于公司及核数师需要额外时间完成审计工作，公司无法按《上市规则》第13.49条规定，于2026年9月30日或之前刊发截至2026年6月30日止年度之业绩报告。根据《上市规则》第13.50条，若公司未能在2026年9月30日前刊发2026年度业绩，其股份买卖预期将于2026年10月2日上午九时正起在香港联交所暂停。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669471671","title":"玮俊生物科技(00660)可能延迟刊发2026年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2669471671","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669471671?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:33","pubTimestamp":1790084023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，由于本公司及其核数师(核数师)需要额外时间完成审计工作，本公司未能于2026年9月30日或之前刊发截至2026年6月30日止年度的年度业绩(2026年度业绩)。本公司正与核数师紧密合作，为尽快完成审计工作程序而提供一切必要资料及文件，惟将需要进一步与核数师讨论及确定年度业绩的预计发布日期，并将适时作出公布。根据上市规则第13.50条，倘发行人未能根据上市规则刊发定期财务资料，香港联合交易所有限公司通常会要求暂停发行人证券的买卖，而暂停买卖通常会持续至发行人刊发载有所需财务资料的公布为止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150192576","title":"玮俊生物科技：若未按期刊发财务信息，或面临停牌风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1150192576","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150192576?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:31","pubTimestamp":1790083871,"startTime":"0","endTime":"0","summary":"玮俊生物科技（00660.HK）近日发出警示——倘若未能如期披露定期财务资料，公司股份可能遭致暂停买卖。这一潜在变数，无疑为投资者敲响了警钟。\n据悉，该警示与公司须按时履行信息披露义务息息相关。若相关财务数据迟迟未能面世，监管层面的停牌程序或将随之启动，令交易活动陷入停滞状态。\n眼下，市场目光正聚焦于这家企业的后续动向。毕竟，定期报告的及时性与准确性，直接关系到股东信心及市场秩序的稳定。一旦停牌成为现实，不仅流动性会受到冲击，公司形象亦难免蒙上阴影。\n现阶段，玮俊生物科技尚未就具体时间表或补救措施给出进一步说明。事态如何演进，仍有待观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128790603","title":"玮俊生物科技（00660）称需额外时间完成审计　2026财年业绩或延迟披露并存停牌风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1128790603","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128790603?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:30","pubTimestamp":1790083851,"startTime":"0","endTime":"0","summary":"董事会经审慎考虑后认为，目前公布未经审计的管理账目或难以准确反映本集团财务表现及／或状况，可能对投资者及股东造成误导。\\n\\n公司董事会确认，目前公司运作正常，业务未受影响。董事会提醒股东及其他投资者在买卖公司证券时应保持审慎，并在需要时咨询专业人士。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191493033","title":"玮俊生物科技更新8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1191493033","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191493033?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:34","pubTimestamp":1788251641,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年9月1日发布8月股份变动月报表，报告期截至2026年8月31日。公司普通股法定股本数量为10,000,000,000股，每股面值0.01港元，对应法定股本总额1亿港元；可换股优先股法定数量为204,000,000股，每股面值0.01港元，对应法定股本总额204万港元。截至本月末，公司合并法定股本总额仍为1.0204亿港元，股本结构保持不变。公告称，截至2026年8月31日，公司股本仍维持稳定，暂无任何新增发行、回购或注销情况。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109843473","title":"玮俊生物科技（00660）补充披露马来西亚AI数据中心项目细节","url":"https://stock-news.laohu8.com/highlight/detail?id=1109843473","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109843473?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:57","pubTimestamp":1788181024,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年8月31日发布补充公告，披露此前8月25日签署的《战略合作谅解备忘录》更多信息。该备忘录涉及在马来西亚彭亨州航空城开发超大型AI数据中心、数字基建平台及AI科技园项目。公告称，各合作方及其最终实益拥有人均为独立于玮俊生物科技及其关连人士的第三方。玮俊生物科技与Radiant组成联合体参与该谅解备忘录。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189841877","title":"玮俊生物科技(00660)签署马来西亚彭亨州航空城AI数据中心等项目战略合作谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=1189841877","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189841877?lang=zh_cn&edition=full","pubTime":"2026-08-25 23:02","pubTimestamp":1787670124,"startTime":"0","endTime":"0","summary":"2026年8月25日，玮俊生物科技有限公司公告称，公司已与Pahang Aerospace City Development Berhad、Baiyuzen Holdings Sdn Bhd、Ennova ICT Pte Ltd及Radiant  Holdings Limited签订关于马来西亚彭亨州航空城综合AI数字基建生态系统项目的战略合作谅解备忘录。谅解备忘录除保密、排他性谈判期、合规及管辖法律等条款外，其商业条款不具法律约束力，项目实施仍需各方进一步评估并签订正式协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108837137","title":"玮俊生物科技2026年7月股份变动月报表，总股本增至384,309,785股","url":"https://stock-news.laohu8.com/highlight/detail?id=1108837137","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108837137?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:41","pubTimestamp":1786005698,"startTime":"0","endTime":"0","summary":"2026年8月6日，玮俊生物科技有限公司发布2026年7月股份变动月报表。公告显示，公司普通股法定股本数为10,000,000,000股，每股面值为0.01港元，对应法定股本1亿港元；可换股优先股法定股本数为204,000,000股，每股面值为0.01港元，对应法定股本204万港元。截至7月末，玮俊生物科技公司法定股本总额为1.0204亿港元。报告期内，普通股已发行股本由367,643,119股增至384,309,785股，新增16,666,666股。根据此次月报，公司已发行股份及股本整体保持稳定，期末普通股股数为384,309,785股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146046205","title":"玮俊生物科技获全球起重机与矿山设备独家海外总代理权","url":"https://stock-news.laohu8.com/highlight/detail?id=1146046205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146046205?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:33","pubTimestamp":1785940388,"startTime":"0","endTime":"0","summary":"玮俊生物科技（Wai Chun Bio Technology）——正式被委任为全球范围内起重设备与矿山机械的独家海外总代理。这一授权标志着该公司在工程机械领域拓展了全新业务版图，从生物科技领域跨界至重型设备分销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116157371","title":"玮俊生物科技：7月7日可换股债券转股1666.67万股，占比4.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116157371","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116157371?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:34","pubTimestamp":1783416843,"startTime":"0","endTime":"0","summary":"玮俊生物科技（股票代码：00660）于2026年7月7日发布公告，披露公司完成一笔金额为100万港元的可换股债券转股，并按每股0.01港元的发行价格增发16,666,666股普通股，折合约1666.67万股，占本次发行前公司已发行股本的4.53%。\n本次增发完成后，公司已发行股本由原先的367,643,119股增至384,309,785股，库藏股份数保持为零。公告显示，此次发行已获公司董事会正式授权，并遵循了香港联合交易所证券上市规则及相关法律法规。公告最后由董事林家俊签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"玮俊生物科技：7月7日可换股债券转股1666.67万股，占比4.53%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649985782","title":"玮俊生物科技(00660.HK)因可换股债券获转换而发行1666.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649985782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649985782?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:30","pubTimestamp":1783416627,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649498578","title":"玮俊生物科技(00660)因可换股债券获转换而发行1666.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649498578","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649498578?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:30","pubTimestamp":1783416627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，于2026年7月7日，该公司金额为100万港元的可换股债券以每股0.01港元转换及发行1666.67万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00660","BK1237","BNDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137130826","title":"玮俊生物科技更新2026年6月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1137130826","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137130826?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:46","pubTimestamp":1783414009,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年7月7日发布了截至2026年6月30日的证券变动月报表。报告显示，报告期内公司股本保持稳定，没有新增发行、购回或注销股份的活动。普通股及可换股优先股在本报告期内未发生增减变动。截至2026年6月30日，普通股实发股本为367,643,119股，与上月持平；优先股以204,000,000股的数量维持不变。公司合计已发行股份无变化，并确认其公开持股量符合香港联交所上市规则的规定。本次月报由执行董事林家俊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169368534","title":"玮俊生物科技公布2026年5月股份变动月报表：当月增发22,500,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1169368534","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169368534?lang=zh_cn&edition=full","pubTime":"2026-06-03 14:41","pubTimestamp":1780468877,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年6月3日发布2026年5月股份变动月报表。截至2026年5月31日，公司法定注册股本维持在港币102,040,000，其中普通股10,000,000,000股、可换股优先股204,000,000股，面值均为港币0.01。报告期内，普通股已发行股份由345,143,119股增至367,643,119股，增加22,500,000股，无库存股变动。根据月报，购股权计划项下的股份期权在本月无新股发行，结存的股份期权数量保持15,954,685份，行使价为每股港币0.25。此外，公司本月未进行任何股份回购或注销活动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635577692","title":"机器人板块逆市走高 卧龙安机器人(06600)涨9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635577692","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635577692?lang=zh_cn&edition=full","pubTime":"2026-05-15 10:57","pubTimestamp":1778813839,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股机器人板块逆市走高，卧龙安机器人  涨 9.26%，兆威机电  涨 9.01%，埃斯顿  涨 8.62%，蓝思科技  涨 6.67%，三花智控  涨 4.46%，优必选  涨 4.11%，极智嘉W  涨 3.64%。消息面上，全国首部具身智能机器人领域地方性法规《杭州市促进具身智能机器人产业发展条例》正式施行，标志着机器人产业从技术探索迈向规范化发展阶段。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0082770016.SGD","LU0620787316.HKD","300433","BK1191","06613","09880","BK1613","LU0348766576.USD","LU0082770016.USD","BK1170","BK1116","00660","002050","002747","BK1183","02715","02590","02692","LU0164939612.USD","SG9999011746.SGD","LU0274383008.USD","003021","02050","BK1214","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635572097","title":"玮俊生物科技(00660)股东将股票存入马银证券(香港) 存仓市值2002.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635572097","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635572097?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:11","pubTimestamp":1778803902,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月14日，玮俊生物科技(00660)股东将股票存入马银证券(香港)，存仓市值2002.50万港元，占比6.12%。此前玮俊生物科技发布公告，于2026年5月5日，该公司根据金额为135万港元的可换股债券以每股0.01港元转换及发行2250万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.0660.hk","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0227},{"period":"3month","weight":0.0238},{"period":"6month","weight":-0.6667},{"period":"1year","weight":1.2396},{"period":"ytd","weight":1.2872}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0136},{"period":"6month","weight":-0.0776},{"period":"1year","weight":-0.0596},{"period":"ytd","weight":-0.0501}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。该公司连同其附属公司主要从事制造及销售变性淀粉及其他生化产品,例如生化精炼油产品。此外，该公司还从事买卖电子元件、组件和器件及电器。","yearOnYearQuotes":[{"month":1,"riseRate":0.393939,"avgChangeRate":0.06724},{"month":2,"riseRate":0.424242,"avgChangeRate":0.11624},{"month":3,"riseRate":0.294118,"avgChangeRate":0.093297},{"month":4,"riseRate":0.30303,"avgChangeRate":0.087332},{"month":5,"riseRate":0.454545,"avgChangeRate":0.014168},{"month":6,"riseRate":0.5,"avgChangeRate":0.037176},{"month":7,"riseRate":0.294118,"avgChangeRate":0.019627},{"month":8,"riseRate":0.176471,"avgChangeRate":-0.03704},{"month":9,"riseRate":0.264706,"avgChangeRate":-0.044174},{"month":10,"riseRate":0.333333,"avgChangeRate":0.028225},{"month":11,"riseRate":0.28125,"avgChangeRate":-0.01241},{"month":12,"riseRate":0.212121,"avgChangeRate":-0.037096}],"exchange":"SEHK","name":"玮俊生物科技","nameEN":"WAI CHUN BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"玮俊生物科技,00660,玮俊生物科技股票,玮俊生物科技股票老虎,玮俊生物科技股票老虎国际,玮俊生物科技行情,玮俊生物科技股票行情,玮俊生物科技股价,玮俊生物科技股市,玮俊生物科技股票价格,玮俊生物科技股票交易,玮俊生物科技股票购买,玮俊生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}